MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations ; volume:22 ; number:1 ; day:18 ; month:6 ; year:2022 ; pages:1-9 ; date:12.2022
BMC cardiovascular disorders ; 22, Heft 1 (18.6.2022), 1-9, 12.2022
- Urheber
-
Lin, Li-rong
Hu, Xue-qun
Lu, Li-hong
Dai, Jia-zhen
Lin, Ning-ning
Wang, Re-hua
Xie, Zhang-xin
Chen, Xue-mei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-022-02714-6
- URN
-
urn:nbn:de:101:1-2022081221162796123906
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lin, Li-rong
- Hu, Xue-qun
- Lu, Li-hong
- Dai, Jia-zhen
- Lin, Ning-ning
- Wang, Re-hua
- Xie, Zhang-xin
- Chen, Xue-mei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Cardiomyopathy, familial dilated
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Cardiomyopathy, familial dilated
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Cardiomyopathy, familial dilated
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene